UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Analysis of the TTR gene in the investigation of amyloidosis: A 25 year single UK centre experience

Rowczenio, D; Quarta, CC; Fontana, M; Whelan, CJ; Martinez-Naharro, A; Trojer, H; Baginska, A; ... Lachmann, HJ; + view all (2019) Analysis of the TTR gene in the investigation of amyloidosis: A 25 year single UK centre experience. Human Mutation , 40 (1) pp. 90-96. 10.1002/humu.23669. Green open access

[thumbnail of Rowczenio_et_al-2018-Human_Mutation.pdf]
Preview
Text
Rowczenio_et_al-2018-Human_Mutation.pdf - Accepted Version

Download (1MB) | Preview

Abstract

Transthyretin amyloidosis (ATTR) is caused by deposition of either wild-type (ATTRwt) or variant (ATTRm) transthyretin. ATTRwt presents with restrictive cardiomyopathy, whilst ATTRm displays a range of organ involvement. This retrospective analysis includes all patients referred to the single UK centre in the last 25 years for clinical and laboratory assessment of known or suspected amyloidosis who underwent TTR gene sequencing. 4459 patients were included in this study; 37% had final diagnosis of ATTR amyloidosis; 27% AL amyloidosis; 0.7% other types of amyloidosis; 21.3% had no amyloid and 14% had no data. TTR variants were found in 770 (17%) cases; the most prevalent were p.V142I, p.T80A and p.V50M identified in 42%, 25% and 16% respectively. The median age at referral in each group was: 76 (range 47-93); 66 (40-81) and 45 years (21-86) respectively. 42 rare or novel variants were identified. 42% of patients with ATTRm died at a median age of 73 years (33-89) with a median survival from diagnosis of 50 months. ATTRwt was the final diagnosis in 20% of patients undergoing genetic testing. Our findings of TTR variants in 17% of screened patients highlights the need for routine genetic testing in the evaluation of suspected ATTR amyloidosis.

Type: Article
Title: Analysis of the TTR gene in the investigation of amyloidosis: A 25 year single UK centre experience
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/humu.23669
Publisher version: https://doi.org/10.1002/humu.23669
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Transthyretin amyloidosis (ATTR); Wild-type (ATTRwt) transthyretin amyloidosis; Variant (ATTRm) transthyretin amyloidosis; TTR gene variants; Neuropathy; Cardiomyopathy
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Renal Medicine
URI: https://discovery.ucl.ac.uk/id/eprint/10059621
Downloads since deposit
307Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item